Source: Medical News Today
Article Date: 21 February 2008 - 3:00 PDT
Summary:
Scientists at Novocell Inc,, a biotechnology company in the field of embryonic stem cell research, implanted immature beta-cells derived from human embryonic stem cells (hES cells) into mice and showed that they generated insulin-secreting cells that responded to raised blood sugar. The study is published in the early online 20 February issue of Nature Biotechnology. They hope the discovery will one day lead to a renewable source of insulin-producing cells for the treatment of diabetes.
